Sign in
TerminatedNo phase

Evaluation of the Abbott i-STAT TBI Biomarker Test

Key facts

Who runs it
Icahn School of Medicine at Mount Sinai
Where
New York, United StatesSee the 3 sites
Trial code
Status
Terminated
People taking part
42 people enrolled
Started
30 Jan 2025
Ended
30 May 2026
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • i-STAT TBI Test
Record updated
15 October 2026
Why it stopped
Study was terminated early due to recruitment limitations and available funding for continued recruitment and follow up

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Age ≥18 years
  • Head injury within 24 hours of research blood collection
  • CT head ordered as part of routine care, not yet completed
  • Glasgow Coma Scale (GCS) 13 - 15

Who cannot take part

  • Previously enrolled in this study in the past 30 days
  • Suspected current ischemic or hemorrhagic stroke
  • History of multiple sclerosis
  • Unknown whether head injury occurred, and signs of head injury are absent
  • Prisoner or in police custody or known pregnancy
  • Suspected open or depressed skull fracture, or signs of skull base fracture
  • Venipuncture not feasible

Where in United States

  • Mount Sinai HospitalNew York, United States
  • Mount Sinai MorningsideNew York, United States
  • Mount Sinai WestNew York, United States

About the trial

What the trial wants to find out

According to the Centers for Disease Control and Prevention, approximately 200,000 hospitalizations occurred in 2020 related to Traumatic Brain Injury (TBI), which does not include many TBIs treated only in emergency departments, urgent care, primary care, or that are not evaluated by a clinician. Head CT is a critical component of care for severe TBI, however in mild TBI there is practice variation with a wider risk to benefit estimation for obtaining head CT imaging. Potential disadvantages of head CT include longer Emergency Department (ED) length of stay (LOS), higher costs, and diagnostic radiation exposure. The i-STAT TBI test is a panel of in vitro diagnostic immunoassays for the quantitative measurements of glial fibrillary acidic protein (GFAP) and ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1) in whole blood and a semi-quantitative interpretation of test results derived from these measurements, using the i-STAT Alinity instrument. This biomarker test is cleared for use in adults with mild TBI (Glasgow Coma Scale 13-15) within 24 hours of injury, to aid in determining the need for head CT imaging. Currently, CT head imaging for adults with suspected mild TBI is obtained based on clinicians' usual practice patterns and beliefs about patient expectations. Prior research has demonstrated the blood TBI test may reduce unnecessary CT scans by up to 40%, however the impact on head CT ordering has not yet been studied prospectively. It is important to understand the extent to which a negative TBI biomarker result empowers a clinician to cancel a previously ordered head CT. Given that adult patients with mild TBI often present to EDs, which have access to CT scanners, this is a key setting to assess real-world impact of the i-STAT TBI test on CT head utilization.

The 2 groups in the trial

  • Notification Arm (Abbott iSTAT TBI test)Treatment being tested

    The ED clinicians caring for the enrolled patient, along with the patient, receive the TBI blood test result with just-in-time education on the TBI test to aid in clinical decision making.

    Treatment: i-STAT TBI Test

  • Non-Notification Arm (Control)No study treatment, for comparison

    Clinicians and enrolled patients do not receive the TBI blood test result.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Evaluation of the Abbott i-STAT TBI Biomarker Test for Effect on Decreasing CT Utilization Among Adult Emergency Department Patients With Suspected Traumatic Brain Injury
Record updated
15 October 2026